MichaelRDebaunMDMPH

Pediatric Hematology & Oncology • Nashville, TN

Pediatric Anemia and Red Blood Cell Hematology

Professor, Pediatrics, Vanderbilt University School of Medicine

Join to view full profile

Dr. Debaun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Debaun's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605

Summary

Dr. Michael Debaun is a pediatric hematologist/oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Monroe Carell Jr. Childrens Hospital and Vanderbilt University Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 30 years. He specializes in pediatric anemia and red blood cell hematology.

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1990 - 1993
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1987 - 1990
Stanford University School of MedicineClass of 1987

Certifications & Licensure

TN State Medical License 2011 - 2026
FL State Medical License 2013 - 2020
MD State Medical License 1992 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 2009

Clinical Trials

Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial Start of enrollment: 2004 Dec 01
Completed
Phase 3
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
Completed
Phase 2
Sickle Cell Disease - Stroke Prevention in Nigeria Trial Start of enrollment: 2013 Apr 24
Completed
Not Applicable
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia Start of enrollment: 2013 Nov 01
Completed
Phase 2
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial Start of enrollment: 2014 Jun 01
Completed
Phase 1
Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II Start of enrollment: 2016 Jul 19
Completed
Phase 3
Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa Start of enrollment: 2017 Jan 01
Completed
Phase 3
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease Start of enrollment: 2016 Sep 01
Withdrawn
Phase 1, Phase 2
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease Start of enrollment: 2017 Jun 02
Recruiting
Management of Severe Acute Malnutrition in SCD, in Northern Nigeria Start of enrollment: 2021 Aug 18
Completed
Phase 2
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) Start of enrollment: 2017 Oct 03
Active, not recruiting
Phase 2
Roles: Contact
Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease Start of enrollment: 2018 Jul 01
Active, not recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

326 citations
Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary
Michael S. Watson, Marie Y. Mann, Michele A. Lloyd-Puryear, Piero Rinaldo, R. Rodney Howell
Pediatrics. 2006-05-01
101 citations
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Res...
Josu de la Fuente, Nathalie Dhedin, Tatsuki Koyama, Françoise Bernaudin, Mathieu Kuentz
Biology of Blood and Marrow Transplantation. 2019-06-01
21 citations
Academic Medicine's Journey Toward Racial Equity Must Be Grounded in History: Recommendations for Becoming an Antiracist Academic Medical Center.
Consuelo H. Wilkins, Mamie Williams, Karampreet Kaur, Michael R. DeBaun
Academic Medicine. 2021-08-24

Journal Articles

Silent Infarcts in Sickle Cell Anemia Occur in the Borderzone Region and Are Associated with Low Cerebral Blood Flow
Lori C Jordan, Andria L Ford, Melanie E Fields, Robert C McKinstry, Michael R DeBaun, Blood
Pregnancy Outcomes in Women with Sickle‐Cell Disease in Low and High Income Countries: A Systematic Review and Meta‐Analysis
Michael R DeBaun, M H Aliyu, M G Tuuli, BJOG: An International Journal of Obstetrics & Gynaecology

Abstracts/Posters

Cross Sectional Survey of Priapism and Sexual Dysfunction in 353 Men with Sickle Cell Disease
Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis
Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507
Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Sickle Cell Disease Post-Transplant Care Challenges in Nigeria: Systematic Institutional Neglect of Medical Tourism
Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
High Levels of Peripheral Vasoconstriction Detected By Polysomnography Predict More Acute Severe Pain Episodes in Children with Sickle Cell Anemia
Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Pediatric Clinical Non-Malignant Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Pediatric Clinical Non-Malignant Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
ASH Clinical Practice Guidelines on Sickle Cell Disease
60th American Society of Hematology Annual Meeting - 12/2/2018
Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease
60th American Society of Hematology Annual Meeting - 12/1/2018
Join now to see all

Other

Overview of the management of sickle cell disease
DeBaun MR, Vichinsky EP, Field JJ
http://www.uptodate.com/contents/overview-of-the-management-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2013-02-21
Diagnosis and management of priapism in sickle cell disease
DeBaun MR, Field JJ, Vemulakonda VM
http://www.uptodate.com/contents/diagnosis-and-management-of-priapism-in-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-04-10
Hepatic manifestations of sickle cell disease
DeBaun MR, Banerjee S
http://www.uptodate.com/contents/hepatic-manifestations-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-04-24
Acute chest syndrome in adults with sickle cell disease
DeBaun MR, Field JJ
http://www.uptodate.com/contents/acute-chest-syndrome-in-adults-with-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2013-04-12
Acute pain management in adults with sickle cell disease
DeBaun MR, Vichinsky EP
http://www.uptodate.com/contents/acute-pain-management-in-adults-with-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-05-01
Join now to see all

Press Mentions

Why Gene Therapy for Sickle Cell Is Slow to Catch on with PatientsSeptember 28th, 2024
ASN Announces Kidney Week Daily Plenary Keynote SpeakersSeptember 16th, 2024
Department of Pediatrics Establishes Dr. Kathryn Edwards SocietySeptember 10th, 2024
Join now to see all

Grant Support

Hydroxyurea To Prevent CNS Complications Of Sickle Cell Disease In ChildrenNational Heart, Lung, And Blood Institute2011
Asthma And Nocturnal Hypoxemia In Sickle Cell Anemia IINational Heart, Lung, And Blood Institute2011
Asthma And Nocturnal Hypoxemia In Sickle Cell Anemia IINational Heart, Lung, And Blood Institute2010
Silent Cerebral Infarct Multi-Center Clinical TrialNational Institute Of Neurological Disorders And Stroke2003–2010
2009 Clinical Research Training Institute Summer WorkshopNational Heart, Lung, And Blood Institute2009
Asthma And Nocturnal Hypoxemia In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2005–2008
Asthma And Nocturnal Hypoxemia In Sickle Cell AnemiaNational Center For Research Resources2007
Screening And Treatment Of Silent Infarcts For Children With Sickle Cell DISENational Center For Research Resources2005–2006
Importance Of Hemodynamic Factors In The Prognosis Of Stroke In Sickle CellNational Center For Research Resources2005–2006
Importance Of Hemodynamic Factors In The Prognosis Of Stroke In Patient With SCDNational Center For Research Resources2005–2006
Increasing Blood And Cord Blood Donation In BlacksNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Feasibility, Safety And Short-Term Efficacy Of Prolonged Ganciclovir ProphylaxisNational Center For Research Resources2004–2005
Pediatric Oncology GroupNational Cancer Institute1997–1999